Stock Information
Jazz Pharmaceuticals PLC (JAZZ)
Ticker Symbol: JAZZ
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $11,546.59 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -5.8455
Revenue (TTM): $69.89 M
Dividend Yield: N/A%
ROE: -8.82%
Latest News
-
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education
Tue, Mar 24, 2026 5:49 PM
-
Compass Therapeutics: Potential Here, But Patience Required
Thu, Mar 19, 2026 3:55 PM
-
Piper Sandler Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $232
Thu, Mar 19, 2026 1:48 PM
-
Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026
Thu, Mar 19, 2026 11:55 AM
-
A Look At Jazz Pharmaceuticals (JAZZ) Valuation As New Oncology Data Heads To The 2026 AACR Meeting
Thu, Mar 19, 2026 10:07 AM
-
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
Wed, Mar 18, 2026 11:46 AM
-
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
Wed, Mar 18, 2026 11:44 AM
-
1 Value Stock to Research Further and 2 We Ignore
Wed, Mar 18, 2026 11:18 AM
-
Zymeworks Announces Jazz Pharmaceuticals To Present Four Abstracts Featuring Data From Clinical Studies Evaluating Ziihera At American Association for Cancer Research Annual Meeting
Wed, Mar 18, 2026 7:47 AM
Key Financials
Financial data not available
